{
    "symbol": "CRNT",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-13 02:24:01",
    "content": " Before we start, I would like to note that certain statements made on this call, including projected financial information and other results and the company's future initiatives, future events, business outlook, development efforts and their potential outcome, anticipated progress and plans, results and time lines and other financial and accounting-related matters constitute forward-looking statements within the meaning of the Securities Act of 1933 as amended, and the Securities Exchange Act of 1934 as amended and the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. We ended the quarter with 33.1% gross margin and $3.2 million in operating profit, which reflects a growth of 113% over the fourth quarter of 2021. Revenues were $75.5 million, a decrease of 3% compared to $77.8 million in Q4 2021 and 4.1% compared to $78.6 million in Q3 2022. Our strongest regions in terms of revenues for the quarter were India and North America, with $21.6 million and $17.2 million, respectively, in line with the continuous strong demand we see in these regions. Gross profit for the fourth quarter on a non-GAAP basis was $25 million, an increase of 10.7% compared to $22.6 million in Q4 2021 and a decrease of 10.6% as compared to $28 million in Q3 2022. As for our operating expenses, research and development expenses for the fourth quarter on a non-GAAP basis were $7.9 million, up from $7.7 million in Q4 2021 and up from $7.2 million in Q3 2022. Sales and marketing expenses for the fourth quarter, on a non-GAAP basis, were $8.6 million, down from $8.7 million in Q4 2021 and up from $8.3 million in Q3 2022. General and administrative expenses for the fourth quarter, on a non-GAAP basis, were $5.4 million, up from $4.6 million in Q4 2021 and down from $6.1 million in Q3 2022. Operating profit for the fourth quarter was $3.2 million, up 113.3% compared to $1.5 million in Q4 2021 and down 50% compared to $6.4 million in Q3 2022. When we take the trailing 12 months view, our non-GAAP operating profit was $9.3 million, a 20.8% increase compared to last quarter's trailing 12 months operating profit of $7.7 million. As for our cash flow, net cash flow used for operations and investing activities in Q4 2022 was $10.6 million, mainly related to the investment in inventory and the onetime expense related to Aviat's hostile attempt recorded in Q3 2022."
}